Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 B cells in autoimmunity.

Literature DB >> 10922029

B cells in autoimmunity.

N A Mitchison¹, L R Wedderburn.

Abstract

Mesh：

Year: 2000 PMID： 10922029 PMCID： PMC34006 DOI： 10.1073/pnas.97.16.8750

Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN： 0027-8424 Impact factor: 11.205

× No keyword cloud information.

20 in total

Review 1. Clinical applications of anti-CD20 antibodies.

Authors: A K Gopal; O W Press
Journal: J Lab Clin Med Date: 1999-11

Review 2. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex.

Authors: D T Fearon; M C Carroll
Journal: Annu Rev Immunol Date: 2000 Impact factor: 28.527

3. Remission of inflammatory arthropathy in association with anti-CD20 therapy for non-Hodgkin's lymphoma.

Authors: A Protheroe; J C Edwards; A Simmons; K Maclennan; P Selby
Journal: Rheumatology (Oxford) Date: 1999-11 Impact factor: 7.580

Review 4. The role of MHC class II molecules in susceptibility and resistance to autoimmunity.

Authors: H O McDevitt
Journal: Curr Opin Immunol Date: 1998-12 Impact factor: 7.486

Review 5. Targeting of cells involved in the pathogenesis of rheumatoid arthritis.

Authors: G S Panayi
Journal: Rheumatology (Oxford) Date: 1999-11 Impact factor: 7.580

Review 6. Anti-cytokine therapy for rheumatoid arthritis.

Authors: R N Maini; P C Taylor
Journal: Annu Rev Med Date: 2000 Impact factor: 13.739

7. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme.

Authors: I Matsumoto; A Staub; C Benoist; D Mathis
Journal: Science Date: 1999-11-26 Impact factor: 47.728

8. Overrepresentation of the Fcgamma receptor type IIA R131/R131 genotype in caucasoid systemic lupus erythematosus patients with autoantibodies to C1q and glomerulonephritis.

Authors: P Norsworthy; E Theodoridis; M Botto; P Athanassiou; H Beynon; C Gordon; D Isenberg; M J Walport; K A Davies
Journal: Arthritis Rheum Date: 1999-09

9. Treatment of humoral rejection after heart transplantation.

Authors: O Grauhan; J Müller; H v Baeyer; H D Volk; E Fietze; T Cohnert; R Meyer; R Pfitzmann; H Mansfeld; H Siniawski; H Warnecke; R Hetzer
Journal: J Heart Lung Transplant Date: 1998-12 Impact factor: 10.247

Review 10. C1q and systemic lupus erythematosus.

Authors: M J Walport; K A Davies; M Botto
Journal: Immunobiology Date: 1998-08 Impact factor: 3.144

13 in total

1. B lymphocytes are resistant to death receptor 5-induced apoptosis.

Authors: Roslyn N Crowder; Hong Zhao; W Winn Chatham; Tong Zhou; Robert H Carter
Journal: Clin Immunol Date: 2011-01-28 Impact factor: 3.969

2. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.

Authors: Jérémie Sellam; Corinne Miceli-Richard; Jacques-Eric Gottenberg; Marc Ittah; Frédéric Lavie; Christine Lacabaratz; Nicolas Gestermann; Alexis Proust; Olivier Lambotte; Xavier Mariette
Journal: Ann Rheum Dis Date: 2006-12-21 Impact factor: 19.103

B cells in autoimmunity.

Review 1. Clinical applications of anti-CD20 antibodies.

Review 2. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex.

3. Remission of inflammatory arthropathy in association with anti-CD20 therapy for non-Hodgkin's lymphoma.

Review 4. The role of MHC class II molecules in susceptibility and resistance to autoimmunity.

Review 5. Targeting of cells involved in the pathogenesis of rheumatoid arthritis.

Review 6. Anti-cytokine therapy for rheumatoid arthritis.

7. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme.

8. Overrepresentation of the Fcgamma receptor type IIA R131/R131 genotype in caucasoid systemic lupus erythematosus patients with autoantibodies to C1q and glomerulonephritis.

9. Treatment of humoral rejection after heart transplantation.

Review 10. C1q and systemic lupus erythematosus.

1. B lymphocytes are resistant to death receptor 5-induced apoptosis.

2. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.

3. Altered frequencies of memory B cells in new-onset systemic lupus erythematosus patients.

4. (99m)Tc-labeled rituximab for imaging B lymphocyte infiltration in inflammatory autoimmune disease patients.

5. Phenotyping of P105-negative B cell subsets in patients with systemic lupus erythematosus.

Review 6. RP105-negative B cells in systemic lupus erythematosus.

7. Targeting CD22 as a strategy for treating systemic autoimmune diseases.

8. Immunomodulatory effects of mesenchymal stromal cells revisited in the context of inflammatory cardiomyopathy.

9. Expression of CXCL12 receptors in B cells from Mexican Mestizos patients with systemic Lupus erythematosus.

10. Rituximab and its potential for the treatment of rheumatoid arthritis.